First human trial of AstraZeneca COVID-19 vaccine shows promise

First human trial of AstraZeneca COVID-19 vaccine shows promise

July 20, 2020 20:21 pm

LONDON, July 20: AstraZeneca’s experimental COVID-19 vaccine was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday. The vaccine, called AZD1222 and being developed by AstraZeneca and scientists at Britain’s University of Oxford, did not prompt any serious side effects and elicited antibody and T-cell immune responses, according to trial results published in The Lancet medical journal.

Trending

thumb-pic1
Nepal to gift two elephants to Qatar during Emir's state visit
thumb-pic1
King of Qatar to hold meeting with PM Dahal, preparations underway to sign six bilateral agreements
thumb-pic1
President Paudel requests Emir of Qatar to help secure release of Bipin Joshi held hostage by Hamas
thumb-pic1
Emir of Qatar returns home after wrapping up state visit to Nepal
thumb-pic1
Qatar Emir meets PM Dahal, bilateral agreement and MoUs signed between Nepal and Qatar
thumb-pic1
NUP Chair Shrestha: Resham Chaudhary, convicted in Tikapur murder case, ineligible for party membership
thumb-pic1
Nepalgunj ICP handed over to Nepal, to come into operation from May 8
thumb-pic1
Prez Paudel solicits Qatar’s investment in Nepal’s water resources, agriculture and tourism sectors
More

Just In